Abstract
Purpose of Review: Elevated cholesterol is an established risk factor for ischemic stroke. The value of statins for stroke prevention has been clear for more than a decade. Recent Findings: However, the use of new medication combinations such as ezetimibe or proprotein convertase subtilisin–kexin type 9 inhibitors plus statins is increasing and the value for reducing stroke has been shown for these combination therapies. Recent data also support the strategy of lowering triglycerides for stroke prevention. Summary: A modern approach to dyslipidemia treatment and its relation to stroke prevention is summarized in this paper.
| Original language | English (US) |
|---|---|
| Article number | 31 |
| Journal | Current neurology and neuroscience reports |
| Volume | 20 |
| Issue number | 8 |
| DOIs | |
| State | Published - Aug 1 2020 |
Keywords
- Cholesterol
- Low-density lipoprotein
- Statins
- Stroke
- Triglycerides
ASJC Scopus subject areas
- Neuroscience(all)
- Clinical Neurology
Fingerprint Dive into the research topics of 'Current Status of Dyslipidemia Treatment for Stroke Prevention'. Together they form a unique fingerprint.
Cite this
Aradine, E., Hou, Y., Cronin, C. A., & Chaturvedi, S. (2020). Current Status of Dyslipidemia Treatment for Stroke Prevention. Current neurology and neuroscience reports, 20(8), [31]. https://doi.org/10.1007/s11910-020-01052-4